Jan 30, 2024
- Company to focus exclusively on commercialization and development of Abecma , in partnership with Bristol Myers Squibb   - - Company to sell R&D pipeline to Regeneron to launch Regeneron Cell Medicines business led by 2seventy bio’s Chief Scientific Officer, Philip Gregory - Chip Baird named